Clinical studies recruiting near Thessaloniki

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Hav
Phase 3 · Theageneio Cancer Hospital of Thessaloniki · Pfizer · NCT05020236 Investigation of Preoperative Factors Influencing the Outcome of Motor Deficits in Patients Undergoing Lumbar Microdiske
Phase N/A · Hippokration General Hospital · Aristotle University Of Thessaloniki · NCT07413302 Observational Study Protocol: LIVER-R
Phase N/A · Research Site · AstraZeneca · NCT06252753 Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT05755386 This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · Athens Medical Center S.A -European Interbalkan Medical Cent · Pfizer · NCT07028853 Apremilast Pediatric Study in Children With Active Oral Ulcers Associated With Behçet's Disease
Phase 3 · General Hospital of Thessaloniki Ippokrateio · Amgen · NCT04528082 Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · European Interbalkan Medical Center ( Site 1502) · Merck Sharp & Dohme LLC · NCT06393374 This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · European Interbalkan Medical Center · Pfizer · NCT06758401 A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney Disease
Phase 3 · Site GR30001 · Astellas Pharma Global Development, Inc. · NCT05970172 A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis
Phase 3 · Hippokration Hospital · Alfasigma S.p.A. · NCT06865417 A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have P
Phase 2 · AHEPA University General Hospital of Thessaloniki · Pfizer · NCT07073820 The Use of a Porcine Collagen Matrix for the Prevention of Buccal Bone Wall Resorption During Implant Placement in the A
Phase 2 · Department of Preventive Dentistry, Periodontology & Imp · Aristotle University Of Thessaloniki · NCT06622759 Positive Psychology for Early Cognitive Decline: Effects on Cognitive and Brain Function
NA · Aristotle University of Thessaloniki · Aristotle University Of Thessaloniki · NCT07289061 A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop
Phase 3 · Interbalkan Medical Center of Thessaloniki · Hoffmann-La Roche · NCT06793215 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Ahepa University Hospital · Amgen · NCT07037433 LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Phase 2 · Ippokrateio General Hospital of Thessaloniki · Eli Lilly and Company · NCT07415044 Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS
Phase 3 · Agios Loukas Clinic · Eli Lilly and Company · NCT06890598 A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic
Phase 3 · Research Site · AstraZeneca · NCT06868277 Hellenic Evaluation of the Long-Term Safety and Efficacy of NalIriFOx as a 1st-line Therapy in Metastatic Pancreatic Duc
Phase N/A · Thessaloniki General Hospital "George Papanikolaou" · Hellenic Cooperative Oncology Group · NCT07723261 A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previ
Phase 3 · Agios Loukas Clinic · Pfizer · NCT07144280 Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcera
Phase 3 · Ippokrateio General Hospital of Thessaloniki · Eli Lilly and Company · NCT06937086 High Frequency RF Current Effects on Muscle Pain and Function
NA · Aristotle University Of Thessaloniki · NCT05345015 A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants Wit
Phase 3 · European Interbalkan Medical Center-Oncology Department ( Si · Merck Sharp & Dohme LLC · NCT06077760 A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone
Phase 3 · G. Papanikolaou General Hospital · Celgene · NCT05519085 Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Phase 3 · General Hospital of Thessaloniki ''Hippokratio'' · Gilead Sciences · NCT06051617 A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in Fi
Phase 3 · European Interbalkan Medical Center · Amgen · NCT07005128 InRAD Observational Study
Phase N/A · Panhellenic Federation of Alzheimer's Disease and Related Di · Stichting International Registry for Alzheimer's Disease and · NCT07213700 A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
Phase 2 · European Interbalkan Medical Center-Oncology Department ( Si · Merck Sharp & Dohme LLC · NCT06833073 A Phase 1b/2a Study of Budoprutug in Subjects With Immune Thrombocytopenia (ITP)
Phase 1/Phase 2 · Climb Bio Investigative Site #300201 · Climb Bio, Inc. · NCT07043946 Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Phase 3 · Kura Oncology, Inc. · NCT07007312

Look up another city

Look up another condition